Operation Bad Blood: The $1.9 Billion Medical Ghost Factory

TUCSON, Ariz. — For the elderly seniors, veterans, and uninsured workers who visited the strip mall storefronts branded as “True Blood Diagnostics,” the experience was remarkably reassuring. Inside, they found a clean, professional environment where a simple walk-in could secure a free blood pressure check, cholesterol screening, or diabetes monitoring. The staff were warm and efficient, and within 72 hours, patients received printed, color-coded health reports that seemed to confirm the state of their well-being. It was a model of accessible, community-focused healthcare.

But as federal agents would later discover, the blood was never tested. It was incinerated.

On the morning of March 11, 2026, the silence of the Arizona desert was broken by the tactical precision of a massive federal crackdown. In a coordinated strike dubbed “Operation Bad Blood,” 43 federal agents descended upon a location in Tucson just as a night-shift technician began feeding patient intake forms into a shredder. Across three states, federal teams hit 31 locations simultaneously, dismantling what investigators now describe as the largest healthcare fraud conspiracy in Arizona history: a $1.9 billion “ghost factory” that billed Medicare and Medicaid for services never performed on patients who never needed them.

A Masterclass in Medical Deception

The mastermind behind the scheme was Derek Harmon, a 39-year-old former pharmaceutical salesman who leveraged his intimate knowledge of healthcare billing to build a labyrinthine fraud network. In October 2023, Harmon leased a modest 12,200-square-foot office in Scottsdale. With little more than a laptop, a phone, and a keen understanding of federal reimbursement loopholes, he identified a critical weakness in the system: the lag between billing and auditing.

“Harmon knew that Medicare reimbursement codes for diagnostic labs were the golden goose,” said one federal investigator. “He also knew that in Arizona, Medicaid audits were running nearly two years behind. He didn’t need to be a doctor; he needed to be an accountant with a cynical eye.”

By late 2023, Harmon had incorporated True Blood Diagnostics, eventually expanding to 14 shell companies across multiple states—a strategy designed to compartmentalize the operation. If one entity triggered an audit, the others remained insulated, continuing to process claims while the flagged division was dissolved or repurposed.

The operation’s efficiency was powered by custom-built software, commissioned from a freelance developer in Kiev, Ukraine, for $285,000 in cryptocurrency. This digital engine was designed to mimic the messy, imperfect nature of human billing—randomizing submission times and introducing minor coding errors—to evade the sophisticated fraud-detection filters used by the Centers for Medicare and Medicaid Services (CMS). Between 2023 and 2026, the system generated over 2.3 million fabricated test orders, netting a staggering $1.41 billion in actual payouts from federal coffers.

The Incineration of Trust

While the paperwork flowed seamlessly into the federal clearinghouse, the reality on the ground was far grimmer. At the 31 True Blood locations, phlebotomists—mostly recent graduates hired at $18 to $22 an hour—performed standard blood draws. They were told the samples were being sent to a central processing lab in Phoenix. In truth, the samples never left the building.

Every evening, courier services collected the biohazard containers from each clinic. But instead of a laboratory, the vans delivered the samples to a medical waste facility in Chandler, Arizona, where they were incinerated daily. Over 11 months, an estimated 340,000 vials of human blood were destroyed without a single diagnostic test being conducted.

The patients, meanwhile, were fed fabricated data. The software generated template-based reports that confirmed what the patients already suspected—that their glucose or cholesterol might be slightly high, or that they were perfectly healthy. Because the results were tailored to avoid causing alarm, “nobody ever questioned good news,” noted one agent.

The billing, however, told a completely different story. A patient who walked into a Tucson strip mall for a free diabetes screening was often billed to the government for an array of comprehensive genetic screenings, cancer biomarker panels, and pharmacogenomic profiles—services that carry high reimbursement rates but require strict medical necessity. A single $0 visit for a patient could generate as much as $38,000 in fraudulent charges.

The Architecture of Complicity

Harmon’s scheme relied on a supply chain of human complicity. He recruited eight licensed physicians as “medical directors,” paying them $15,000 a month through shell companies to sign thousands of standing orders they never reviewed. Dr. Patricia Langford, an internist in Albuquerque, was found to have signed over 400 standing orders per month from her home office, unknowingly—or perhaps willfully—authorizing the exploitation of hundreds of millions of dollars in federal funds under her National Provider Identifier (NPI).

The most shocking revelation, however, was the involvement of Roland Vickers, a deputy administrator at the Arizona Health Care Cost Containment System (AHCCCS), the state’s Medicaid agency. Vickers was the “fox in the henhouse,” paid $620,000 in bribes to ensure that any red flags raised by lower-level analysts were suppressed. When junior auditors flagged the impossible volume of genetic testing at the Scottsdale clinics—volumes that would have required massive laboratory infrastructure the clinics clearly didn’t possess—Vickers intervened directly, reassigning the cases to his own queue and letting them die in silence.

The Unraveling

The end of the $1.9 billion empire began with a phlebotomist named Maria Selenus. Working for $19.50 an hour at the East Speedway location in Tucson, Selenus became suspicious when she noticed that the blood samples she collected were routinely discarded into waste bins rather than prepared for transport. In November 2025, she contacted the FBI’s Phoenix field office.

Her report reached Special Agent Christine Novak, who ran a cursory check on True Blood’s billing. She discovered that a network of walk-in clinics was billing Medicare for nearly $850 million in a single year—seven times the amount claimed by the largest, most reputable laboratory chain in the state. The discrepancy was so large it was mathematically impossible.

“When you see a number like that, you know you aren’t looking at a medical operation,” Novak said. “You’re looking at a financial crime disguised as a doctor’s office.”

Operation Bad Blood officially launched within 48 hours of Selenus’s call. The task force—a joint effort involving the FBI, HHS Office of Inspector General, and the DOJ’s Healthcare Fraud Strike Force—spent the next four months conducting a masterclass in surveillance. They tracked courier routes, mirrored servers in the Tempe data center, and mapped the flow of money from Medicare to the offshore accounts Harmon used to fund his lavish lifestyle, which included a $2.8 million Paradise Valley home and a $340,000 Ferrari.

A Reckoning in the Desert

When the raids finally struck on March 11, the evidence gathered was overwhelming. In addition to the massive digital footprint left on the servers, agents recovered shredded intake forms, partially processed blood samples that had been slated for incineration, and a notebook in Harmon’s possession that contained hand-calculated projections of how much the federal government would pay out for specific, fake medical codes.

Forty-six individuals are now under indictment, including Harmon, the complicit physicians, and the corrupt state official, Vickers. Charges include conspiracy to commit healthcare fraud, wire fraud, money laundering, and bribery of a public official. For Harmon, the maximum sentencing exposure could exceed the duration of his natural life.

As federal prosecutors move toward trial, the case has sent shockwaves through the healthcare and regulatory communities. It has raised uncomfortable questions about how a ghost network of 31 clinics could bleed the federal system for nearly $2 billion before a single whistle-blower stepped forward.

For the patients caught in the web—the elderly postal worker in Mesa who was billed $187,000 for three blood sugar checks, or the families who trusted the “True Blood” brand—the betrayal is profound. Their personal and medical data, harvested to power a billion-dollar fraud machine, remains a lingering concern.

At the FBI’s Phoenix field office, the investigation is still ongoing. The $380 million wired to foreign jurisdictions has yet to be fully tracked, and the final tally of the fraud’s human cost is still being calculated. Operation Bad Blood stands as a stark warning: in an age of automated billing and digital healthcare, the most dangerous predator is no longer the one who wields a scalpel, but the one who wields a line of code. For Derek Harmon, the man who thought he had gamed the system, the reality of a federal courtroom has finally brought an end to the charade.